[Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma]. / Porównanie skutecznosci adriamycyny i epirubicyny stosowanych w schemacie CHOP u chorych na nieziarnicze chloniaki zlosliwe.
Wiad Lek
; 46(9-10): 356-9, 1993 May.
Article
en Pl
| MEDLINE
| ID: mdl-8236992
In a group of 30 patients with the diagnosis of malignant non-Hodgkin lymphoma of high histological malignancy, a prospective randomized study was carried out concerning the effectiveness and toxicity of the CHOP chemotherapy using adriamycin vs epirubicin. The effectiveness and tolerance of both treatment programmes are comparable. Good tolerance of the used epirubicin dose encourages to its increase in combined chemotherapy programmes in order to achieve higher therapeutic effectiveness.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Linfoma no Hodgkin
/
Protocolos de Quimioterapia Combinada Antineoplásica
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Pl
Revista:
Wiad Lek
Asunto de la revista:
MEDICINA
Año:
1993
Tipo del documento:
Article
Pais de publicación:
Polonia